Identification of human papillomavirus in oral rinse specimens from women with and without cervical intraepithelial lesions.


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
09 2020
Historique:
received: 06 11 2019
revised: 14 01 2020
accepted: 28 01 2020
pubmed: 13 2 2020
medline: 12 9 2020
entrez: 13 2 2020
Statut: ppublish

Résumé

The objective of this study was to evaluate the frequency of human papillomavirus (HPV) in the oral cavity of women with and without abnormal cervical cytology and to determine whether there is an association of oral HPV infection with infection of the cervix or with cervical cancer precursor lesions. The present study was conducted among 406 women, aged 18-82 years, who attended the Prevention Department of Barretos Cancer Hospital (HCB), Brazil due to a previous altered cervical cytology result. Oral rinse, cervical cytology and biopsy were collected at the same day. The participants also answered a questionnaire about socioeconomic characteristics and risk factors for cervical cancer. Molecular screening for HPV16, HPV18 and 12 other high-risk HPV types was performed on cervical and oral rinse specimens using Cobas 4800 (Roche Molecular Systems, USA). HPV was detected in the oral rinse of 3.9% of participants. Infection of the oral cavity with a non-HPV16 or 18 type was most frequent (81.2%), followed by HPV16 (18.7%). Infection with HPV in the cervix and oral cavity was present in 11 (2.7%) of participants. There were no differences observed in the smoking status (p value 0.62), mean age of first sexual intercourse (p value 0.25), mean age of the first oral sex (p value 0.90) or mean lifetime number of sexual partners (p value 0.08) between the participants with oral HPV infection or not. The presence of HPV infection in the oral cavity was low in the group of women with abnormal cervical cancer screening findings and a high rate of cervical HPV infection.

Identifiants

pubmed: 32047004
pii: sextrans-2019-054359
doi: 10.1136/sextrans-2019-054359
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

408-410

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Isabela Nemesio (I)

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

Fernanda Cury (F)

Center for Research Support, Barretos Cancer Hospital, Barretos, Brazil.

Adhemar Longatto-Filho (A)

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
Institute of Life and Health Sciences, University of Minho, Braga, Portugal.

José Humberto Fregnani (JH)

Teaching and Research Institute, Barretos Cancer Hospital, Barretos, Brazil.
Teaching and Learning Department, A.C. Camargo Cancer Center, Sao Paulo, Brazil.

Laura Musselwhite (L)

Duke Cancer Institute, Duke University, Durham, North Carolina, USA.

Fabiana Vazquez (F)

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

Ana Carolina Peters (AC)

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

Cristina Oliveira (C)

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil cristina.oliveira1@gmail.com.
Institute of Life and Health Sciences, University of Minho, Braga, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH